News for Novozymes A/S (NZYMN.MX)

Landmark investments, portfolio progress, and expanded presence position

Landmark investments, portfolio progress, and expanded presence position

May 08, 2025 / 07:00AM GMTOperator Ladies and gentlemen, welcome to the Novonesis Q1 2025 conference call. I am Healy, the Chorus Call operator. (Operator Instr

**media[585369]**

**media[574537]**

**media[574293]**

**media[571435]**

**media[551828]**

Feb 26, 2025 / 08:00AM GMTTobias Bjorklund - Novozymes A/S-Head of Investor Relations Thank you very much, operator, and welcome, everyone, to the Novonesis con

**media[542970]**

The latest research document on “Global Bioremediation Technology Market Size, Share, Sales and Forecast” Published by HTF MI with 143+ pages. The Study is segmented by key a region that is…

**media[504788]**

Denmark stocks lower at close of trade; OMX Copenhagen 20 down 1.51%

Catalent, Inc. (”œCatalent,” NYSE: CTLT), a leader in enabling the development and supply of better treatments for patients worldwide, and Novo Holdings A/S

Denmark stocks higher at close of trade; OMX Copenhagen 20 up 0.62%

Denmark stocks higher at close of trade; OMX Copenhagen 20 up 3.01%

Denmark stocks lower at close of trade; OMX Copenhagen 20 down 1.60%

**media[471847]**

Denmark stocks higher at close of trade; OMX Copenhagen 20 up 1.48%